REGULATORY

Drugs Being Delivered to Quake-Hit Areas Day after Request: Minister

January 10, 2024

Japan has been able to secure the next-day delivery of pharmaceuticals in central Japan areas struck by a powerful New Year’s Day earthquake, albeit depending on road conditions, Health Minister Keizo Takemi said on January 9.

The quake mainly battered Ishikawa Prefecture’s Noto Peninsula on the Sea of Japan coast. Speaking in a regular press conference, Mr Takemi explained that there are two routes to take requests for drug supplies to the region: 1) the Ishikawa prefectural government receives requests from medical institutions and then contacts local wholesalers, and 2) medical institutions directly send requests to wholesalers.

Requests not only include acute-care medicines needed immediately after the disaster, such as antimicrobials to treat trauma, but also insulin therapies for diabetes, among other treatments, the minister said.

“We have basically been able to distribute these medicines to local medical institutions the day after (the request), although it depends on road conditions,” he said.

On January 7, a mobile pharmacy vehicle reached the northern part of the peninsula called Oku-Noto, and it is now primarily operating in the city of Suzu. He said one more such vehicle will be added on January 9, which will mainly operate in the city of Wajima. “We’ll be dispatching more vehicles once local situations are confirmed,” he said.

REGULATORY

Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…

By Ken Yoshino

Japan’s health and finance ministers agreed late last year to go ahead with an “off-year” drug price revision in FY2027,…

By Philip Carrigan

The Japanese healthcare sector is experiencing rapid growth, demanding a highly skilled and diverse workforce. However, finding and attracting the best talent in this competitive market presents significant challenges.Enter AI. With the rise of AI-powered tools, healthcare organizations can revolutionize…

Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…

By Ken Yoshino

The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…

The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…

Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…

Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…